Your browser doesn't support javascript.
loading
Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study.
Pula, Bartosz; Iskierka-Jazdzewska, Elzbieta; Dlugosz-Danecka, Monika; Szymczyk, Agnieszka; Hus, Marek; Szeremet, Agnieszka; Drozd-Sokolowska, Joanna; Waszczuk-Gajda, Anna; Zaucha, Jan M; Holojda, Jadwiga; Piszczek, Weronika; Steckiewicz, Pawel; Wojciechowska, Malgorzata; Osowiecki, Michal; Knopinska-Posluszny, Wanda; Dudzinski, Marek; Zawirska, Daria; Subocz, Edyta; Halka, Janusz; Pluta, Andrzej; Wichary, Ryszard; Kumiega, Beata; Budziszewska, Bozena K; Jurczak, Wojciech; Lech-Maranda, Ewa; Giannopoulos, Krzysztof; Robak, Tadeusz; Jamroziak, Krzysztof.
Afiliação
  • Pula B; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland bartosz.pula@gmail.com.
  • Iskierka-Jazdzewska E; Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland.
  • Dlugosz-Danecka M; Department of Clinical Oncology, Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland.
  • Szymczyk A; Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.
  • Hus M; Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.
  • Szeremet A; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Drozd-Sokolowska J; Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Waszczuk-Gajda A; Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Zaucha JM; Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland.
  • Holojda J; Department of Hematology, Specialist District Hospital, Legnica, Poland.
  • Piszczek W; Department of Hematology, Copernicus Hospital, Torun, Poland.
  • Steckiewicz P; Department of Hematology, Holycross Cancer Center, Kielce, Poland.
  • Wojciechowska M; Department of Hematology, Specialist District Hospital, Olsztyn, Poland.
  • Osowiecki M; Department of Lymphoid Malignancies, Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw, Poland.
  • Knopinska-Posluszny W; Department of Hematology, Independent Public Health Care of the Ministry of the Internal Affairs with the Oncology Centre, Olsztyn, Poland.
  • Dudzinski M; Department of Hematology, Specialist District Hospital, Rzeszow, Poland.
  • Zawirska D; Department of Hematology, Jagiellonian University, Krakow, Poland.
  • Subocz E; Department of Hematology, Military Institute of Medicine, Warsaw, Poland.
  • Halka J; Department of Hematology, Military Institute of Medicine, Warsaw, Poland.
  • Pluta A; Department of Hematological Oncology, Regional Specialist Hospital, Brzozow, Poland.
  • Wichary R; Department of Hematology and Bone Marrow Transplantation, Katowice Medical Department, Silesian Medical University, Katowice, Poland.
  • Kumiega B; Department of Hematology, Specialist District Hospital, Nowy Sacz, Poland.
  • Budziszewska BK; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Jurczak W; Department of Clinical Oncology, Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland.
  • Lech-Maranda E; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Giannopoulos K; Department of Hematology and Transfusion Medicine, Centre of Postgraduate Medical Education, Warsaw, Poland.
  • Robak T; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
  • Jamroziak K; Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland.
Anticancer Res ; 40(7): 4059-4066, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32620653

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Leucemia Linfocítica Crônica de Células B / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Anticancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Polônia País de publicação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Leucemia Linfocítica Crônica de Células B / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Anticancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Polônia País de publicação: Grécia